2XXI
Crystal structure of 1-((4-(3-(trifluoromethyl)-6,7-dihydropyrano(4,3- c(pyrazol-1(4H)-yl)phenyl)methyl)-2-pyrrolidinone in complex with the ligand binding domain of the Rat GluA2 receptor and glutamate at 1.6A resolution.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-1 |
Synchrotron site | ESRF |
Beamline | ID23-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Detector | ADSC CCD |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 114.433, 163.357, 47.336 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 93.660 - 1.600 |
R-factor | 0.19094 |
Rwork | 0.190 |
R-free | 0.20846 |
Structure solution method | OTHER |
Starting model (for MR) | NONE |
RMSD bond length | 0.009 |
RMSD bond angle | 1.184 |
Data reduction software | HKL |
Data scaling software | SCALEPACK |
Refinement software | REFMAC (5.5.0109) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 40.000 | 1.630 |
High resolution limit [Å] | 1.600 | 1.600 |
Rmerge | 0.090 | 0.450 |
Number of reflections | 114891 | |
<I/σ(I)> | 20.5 | 2.6 |
Completeness [%] | 98.0 | 94.9 |
Redundancy | 5.4 | 5.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 |